Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

W. Stone, Gregg; E. Bertrand, Michel; W. Moses, Jeffrey; Magnus Ohman, E.; Michael Lincoff, A.; H. Ware, James; Pocock, Stuart; McLaurin, Brent; A. Cox, David; Zubair Jafar, M.; Chandna, Harish; Hartmann, Franz; Leisch, F; H. Strasser, Ruth; Desaga, Martin; Stuckey, Thomas; Zelman, Richard; Lieber, Ira; J. Cohen, David; Mehran, Roxana; D. White, Harvey; the ACUITY Investigators, for

doi:10.1001/jama.297.6.591

Public

Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

Published in JAMA • Feb 13, 2007

Authors:

Gregg W. Stone

Michel E. Bertrand

Jeffrey W. Moses

Abstract

CONTEXT: In patients with moderate- and high-risk acute coronary syndromes (ACS) who undergo an early, invasive treatment strategy, current guidelines recommend administration of platelet glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibitors, either upstream to all patients prior to angiography or deferred...

Subject

Medicine

Revascularization

Myocardial infarction

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!